M&A · Healthcare · Buyer's industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries
BIMI International Medical Inc. to acquire Phenix Bio Inc.
Announced Jul 7, 2022 · Closed Mar 15, 2023 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationCash and stock$0.60 per share
Transaction
- Acquirer
- BIMI International Medical Inc. (BIMI)
- Target
- Phenix Bio Inc.
- Buyer type
- Strategic
- Offer price per share
- $0.60
- Enterprise value
- —
- Status
- Closed Mar 15, 2023
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries